Home » Teva, Ivax See Revenue Rise in Second Quarter 2005
Teva, Ivax See Revenue Rise in Second Quarter 2005
August 9, 2005
Ivax’s revenues in all its major business regions increased in the second quarter of 2005 compared to the same period last year, the company said. North American revenues rose 14 percent from $228.3 million to $261 million on the strength of its U.S. generics business, Ivax said.